Hepatitis B Vaccine (Recombinant) Recruiting Phase 3 Trials for Meningococcal Infections Prevention

clinicaltrials.gov IdentifierTitleDrugs
NCT03621670GlaxoSmithKline's (GSK) Safety and Immunogenicity Study of GSK Meningococcal Group B and 13-valent Pneumococcal Vaccines Administered Together With Routine Infant Vaccines in Healthy Infants
NCT03537508Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US